We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00766558
First Posted: October 6, 2008
Last Update Posted: June 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Milton S. Hershey Medical Center
  Purpose
A technique that has been found to be effective at relieving the physical and psychological symptoms associated with inhibiting emotions and emotional thoughts is written emotional disclosure. The goal of this study is to evaluate the effectiveness of written emotional disclosure on the remediation of eating disorder behaviour, cognitions, and management of emotions.

Condition
Anorexia Nervosa Bulimia Nervosa Eating Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of the Efficacy of Written Emotional Disclosure on Eating Disorder Pathology

Resource links provided by NLM:


Further study details as provided by Milton S. Hershey Medical Center:

Primary Outcome Measures:
  • Testing and behavioral changes [ Time Frame: 6-weeks ]

Enrollment: 29
Study Start Date: June 2009
Study Completion Date: July 2013
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1 Disclosure
Traumatic writing prompts provided. Participant is assigned a potential stress-producing topic for written disclosure.
2 control
Received nontraumatic writing prompts. Participant assigned a non-stressful writing condition

Detailed Description:
New Partial program participants complete a packet of questionnaires during their initial appointment, which will be used as baseline levels of eating disorder symptoms and psychological health. Participants will complete the writing as part of their eating disorder therapy. The writing will be completed individually. The writing will consist of continuous writing for fifteen minutes on three consecutive days. The experimental group will write about traumatic or stressful experiences, while the control group will objectively describe events. A post-writing packet of questionnaires will be completed one week after completing the writing. A follow-up evaluation will occur four-weeks after completion of the post-writing packet and will include completing a packet of questionnaires and debriefing.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients in the Penn State Hershey Adolescentand Adult Eating Disorders Partial Hospitalization Program
Criteria

Inclusion Criteria:

  • Willing to sign consent form

Exclusion Criteria:

  • Unwilling to sign consent form
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00766558


Locations
United States, Pennsylvania
Penn State College of Medicine
Hershey, Pennsylvania, United States, 17033
Sponsors and Collaborators
Milton S. Hershey Medical Center
Investigators
Principal Investigator: Richard L Levine, MD Penn State College of Medicine
  More Information

Publications:
Pennebaker, J. W., Chung, C. K., Ireland, M., Gonzales, A., and Booth, R. J. (2007). The development and psychometric properties of LIWC2007. Retrieved June 1, 2008, from Linguistic Inquiry and Word Count web site http://www.LIWC.net/liwcdescription.php
Pennebaker, J. W. and Francis, M. E. (1996). Cognitive, emotional, and language processes in disclosure. Cognition and Emotion, 10, 601-626.
Quinton, S. and Wagner, H. L. (2005). Emotional expression, alexithymia, and characteristics associated with eating psychopathology in non-clinical women. Personality and Individual Differences, 38, 1163-1173.

Responsible Party: Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier: NCT00766558     History of Changes
Other Study ID Numbers: 28860
First Submitted: October 3, 2008
First Posted: October 6, 2008
Last Update Posted: June 20, 2017
Last Verified: June 2017

Keywords provided by Milton S. Hershey Medical Center:
anorexia
bulimia
eating disorder not otherwise specified

Additional relevant MeSH terms:
Disease
Feeding and Eating Disorders
Anorexia
Anorexia Nervosa
Bulimia
Bulimia Nervosa
Pathologic Processes
Mental Disorders
Signs and Symptoms, Digestive
Signs and Symptoms
Hyperphagia